This clearly suggests that the three possible positive steroid receptor breast cancer phenotypes (ER+PgR+, ER+PgR− and the rare ER−PgR+) may be biologically different, particularly in this early phase of tumor growth, during tissue invasion. Here, PGR is linked to neoplasm.